A side-by-side comparison of T cell reactivity to fifty-nine Mycobacterium tuberculosis antigens in diverse populations from five continents

Tuberculosis

Volumn 95, Issue 6, 2015, Pages 713-721

  Carpenter, Chelsea ^a   Sidney, John ^a   Kolla, Ravi ^a   Nayak, Kaustuv ^b   Tomiyama, Helena ^c   Tomiyama, Claudia ^c   Padilla, Oscar A ^c   Rozot, Virginie ^d   Ahamed, Syed F ^e   Ponte, Carlos ^f   Rolla, Valeria ^f   Antas, Paulo R ^f   Chandele, Anmol ^b   Kenneth, John ^e   Laxmi, Seetha ^e   Makgotlho, Edward ^d   Vanini, Valentina ^g   Ippolito, Giuseppe ^g   Kazanova, Alexandra S ^h   Panteleev, Alexander V ^h   Hanekom, Willem ^d   Mayanja Kizza, Harriet ⁱ   Lewinsohn, David ^j   Saito, Mayuko ^k,l,m   McElrath, M Juliana ⁿ   Boom, W Henry ^o   Goletti, Delia ^g   Gilman, Robert ^k,l   Lyadova, Irina V ^h   Scriba, Thomas J ^d   Kallas, Esper G ^c   Murali Krishna, Kaja ^b,p,q   Sette, Alessandro ^a   Lindestam Arlehamn, Cecilia S ^a   more..

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY ICGEB   (India)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^f INSTITUTO OSWALDO CRUZ   (Brazil)

^g NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^h CENTRAL TUBERCULOSIS RESEARCH INSTITUTE   (Russian Federation)

ⁱ MAKERERE UNIVERSITY   (Uganda)

^j OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^k JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^l UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^m TOHOKU UNIVERSITY   (Japan)

ⁿ Fred Hutchinson Cancer Research Center   (United States)

^o CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p EMORY UNIVERSITY   (United States)

^q EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

BCG; CD4; LTBI; T cell antigen; Tuberculosis; Vaccine

Indexed keywords

BACTERIAL ANTIGEN; BCG VACCINE; GAMMA INTERFERON; T LYMPHOCYTE ANTIGEN;

AFRICA; ANTIGEN RECOGNITION; ARTICLE; ASIA; BCG VACCINATION; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELLULAR IMMUNITY; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; EUROPE; EX VIVO STUDY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; MALE; MICROBIAL DIVERSITY; MULTICENTER STUDY; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; WESTERN HEMISPHERE; ADOLESCENT; ADULT; AGED; BRAZIL; CHILD; CLINICAL TRIAL; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INDIA; LATENT TUBERCULOSIS; MICROBIOLOGY; MIDDLE AGED; SOUTH AFRICA; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIGENS, BACTERIAL; BCG VACCINE; BRAZIL; CD4-POSITIVE T-LYMPHOCYTES; CHILD; EUROPE; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; INDIA; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SOUTH AFRICA; UNITED STATES; YOUNG ADULT;

EID: 84948718070     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2015.07.001     Document Type: Article

References (50)

1. G.W. Comstock Epidemiology of tuberculosis Am Rev Respir Dis 125 1982 8 15
2. S.H. Kaufmann Is the development of a new tuberculosis vaccine possible? Nat Med 6 2000 955 960
3. J.R. Andrews, F. Noubary, R.P. Walensky, R. Cerda, E. Losina, and C.R. Horsburgh Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis Clinical infectious diseases vol. 54 2012 An official publication of the Infectious Diseases Society of America 784 791
4. C.S. Lindestam Arlehamn, D. Lewinsohn, A. Sette, and D. Lewinsohn Antigens for CD4 and CD8 T cells in tuberculosis Cold Spring Harb Perspect Med 4 2014 a018465
5. G.M. Winslow, A. Cooper, W. Reiley, M. Chatterjee, and D.L. Woodland Early t-cell responses in tuberculosis immunity Immunol Rev 225 2008 284 299
6. M.D. Tameris, M. Hatherill, B.S. Landry, and et al. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial Lancet 381 2013 1021 1028
7. C.L. Karp, C.B. Wilson, and L.M. Stuart Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool Immunol Rev 264 2015 363 381
8. S.H. Kaufmann, G. Hussey, and P.H. Lambert New vaccines for tuberculosis Lancet 375 2010 2110 2119
9. M. Coscolla, and S. Gagneux Consequences of genomic diversity in Mycobacterium tuberculosis Semin Immunol 26 2014 431 444
10. S. Gagneux, K. DeRiemer, T. Van, and et al. Variable host-pathogen compatibility in Mycobacterium tuberculosis Proc Natl Acad Sci USA 103 2006 2869 2873
11. J. Greenbaum, J. Sidney, J. Chung, C. Brander, B. Peters, and A. Sette Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes Immunogenetics 63 2011 325 335
12. D.M. McKinney, S. Southwood, D. Hinz, and et al. A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population Immunogenetics 65 2013 357 370
13. S. Paul, C.S. Lindestam Arlehamn, T.J. Scriba, and et al. Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes J Immunol Methods 422 2015 28 34
14. G.A. Colditz, C.S. Berkey, F. Mosteller, and et al. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature Pediatrics 96 1995 29 35
15. P.E. Fine Variation in protection by BCG: implications of and for heterologous immunity Lancet 346 1995 1339 1345
16. B.B. Trunz, P. Fine, and C. Dye Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness Lancet 367 2006 1173 1180
17. M.A. Behr, and P.M. Small A historical and molecular phylogeny of BCG strains Vaccine 17 1999 915 922
18. N. Ritz, W.A. Hanekom, R. Robins-Browne, W.J. Britton, and N. Curtis Influence of BCG vaccine strain on the immune response and protection against tuberculosis FEMS Microbiol Rev 32 2008 821 841
19. V. Davids, W.A. Hanekom, N. Mansoor, and et al. The effect of bacille Calmette-Guerin vaccine strain and route of administration on induced immune responses in vaccinated infants J Infect Dis 193 2006 531 536
20. P. Gorak-Stolinska, R.E. Weir, S. Floyd, and et al. Immunogenicity of Danish-SSI 1331 BCG vaccine in the UK: comparison with Glaxo-Evans 1077 BCG vaccine Vaccine 24 2006 5726 5733
21. V. Vijayalakshmi, K.J. Murthy, S. Kumar, and A.L. Kiran Comparison of the immune responses in children vaccinated with three strains of BCG vaccine Indian Pediatr 32 1995 979 982
22. C.S. Lindestam Arlehamn, A. Gerasimova, F. Mele, and et al. Memory T cells in latent Mycobacterium tuberculosis infection are directed against three antigenic Islands and largely contained in a CXCR3+CCR6+ Th1 subset PLoS Pathog 9 2013 e1003130
23. A. Zwerling, M.A. Behr, A. Verma, T.F. Brewer, D. Menzies, and M. Pai The BCG world atlas: a database of global BCG vaccination policies and practices PLoS Med 8 2011 e1001012
24. R. Copin, M. Coscolla, E. Efstathiadis, S. Gagneux, and J.D. Ernst Impact of in vitro evolution on antigenic diversity of Mycobacterium bovis bacillus Calmette-Guerin (BCG) Vaccine 32 2014 5998 6004
25. J.S. Sutherland, M.K. Lalor, G.F. Black, and et al. Analysis of host responses to Mycobacterium tuberculosis antigens in a multi-site study of subjects with different TB and HIV infection states in sub-Saharan Africa PLoS One 8 2013 e74080
26. G.F. Black, B.A. Thiel, M.O. Ota, and et al. Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa Clin vaccine Immunol 16 2009 1203 1212 CVI
27. S.H. Kaufmann Tuberculosis vaccines: time to think about the next generation Semin Immunol 25 2013 172 181
28. M. Harboe, T. Oettinger, H.G. Wiker, I. Rosenkrands, and P. Andersen Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG Infect Immun 64 1996 16 22
29. S. D'Souza, V. Rosseels, M. Romano, and et al. Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis Infect Immun 71 2003 483 493
30. H. McShane, A.A. Pathan, C.R. Sander, and et al. Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans Nat Med 10 2004 1240 1244
31. T.J. Scriba, M. Tameris, N. Mansoor, and et al. Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants J Infect Dis 203 2011 1832 1843
32. P. Andersen, T.M. Doherty, M. Pai, and K. Weldingh The prognosis of latent tuberculosis: can disease be predicted? Trends Mol Med 13 2007 175 182
33. C.E. Barry 3rd, H.I. Boshoff, V. Dartois, and et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies Nat Rev Micro 7 2009 845 855
34. C. Aagaard, T. Hoang, J. Dietrich, and et al. A multistage tuberculosis vaccine that confers efficient protection before and after exposure Nat Med 17 2011 189 194
35. S. Commandeur, K.E. van Meijgaarden, C. Prins, and et al. An unbiased genome-wide Mycobacterium tuberculosis gene expression approach to discover antigens targeted by human T cells expressed during pulmonary infection J Immunol 190 2013 1659 1671
36. L. Shi, R. North, and M.L. Gennaro Effect of growth state on transcription levels of genes encoding major secreted antigens of Mycobacterium tuberculosis in the mouse lung Infect Immun 72 2004 2420 2424
37. A. Demissie, E.M.S. Leyten, M. Abebe, and et al. Recognition of stage-specific mycobacterial antigens differentiates between Acute and latent infections with Mycobacterium tuberculosis Clin Vaccine Immunol 13 2006 179 186
38. E.M.S. Leyten, M.Y. Lin, K.L.M.C. Franken, and et al. Human t-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis Microbes Infect 8 2006 2052 2060
39. S.D. Schuck, H. Mueller, F. Kunitz, and et al. Identification of T-cell antigens specific for latent Mycobacterium Tuberculosis infection PLoS ONE 4 2009 e5590
40. D. Goletti, O. Butera, V. Vanini, and et al. Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection Eur Respir J 36 2010 135 142
41. I. Comas, J. Chakravartti, P.M. Small, and et al. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved Nat Genet 42 2010 498 503
42. N. Gey van Pittius, S. Sampson, H. Lee, Y. Kim, P. van Helden, and R. Warren Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions BMC Evol Biol 6 2006 95
43. S.G. Reed, R.N. Coler, W. Dalemans, and et al. Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys Proc Natl Acad Sci USA 106 2009 2301 2306
44. K. Von Eschen, R. Morrison, M. Braun, and et al. The candidate tuberculosis vaccine Mtb72F/AS02A: tolerability and immunogenicity in humans Hum Vaccin 5 2009 475 482
45. F. Spertini, R. Audran, F. Lurati, and et al. The candidate tuberculosis vaccine Mtb72F/AS02 in PPD positive adults: a randomized controlled phase I/II study Tuberc (Edinb) 93 2013 179 188
46. J. Montoya, J.A. Solon, S.R. Cunanan, and et al. A randomized, controlled dose-finding phase II study of the M72/AS01 candidate tuberculosis vaccine in healthy PPD-positive adults J Clin Immunol 33 2013 1360 1375
47. C.L. Day, M. Tameris, N. Mansoor, and et al. Induction and regulation of t-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults Am J Respir Crit Care Med 188 2013 492 502
48. I. Leroux-Roels, S. Forgus, F. De Boever, and et al. Improved CD4(+) T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: a randomized trial Vaccine 31 2013 2196 2206
49. O.T. Idoko, O.A. Owolabi, P.K. Owiafe, and et al. Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: an open-label randomized controlled trial Tuberc (Edinb) 94 2014 564 578
50. J.M. Lew, A. Kapopoulou, L.M. Jones, and S.T. Cole TubercuList - 10 years after Tuberculosis 91 2011 1 7